Coldstream Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $574K | Sell |
1,094
-244
| -18% | -$128K | 0.01% | 600 |
|
|
2025
Q1 | $849K | Buy |
1,338
+27
| +2% | +$17.1K | 0.02% | 414 |
|
|
2024
Q4 | $934K | Buy |
1,311
+2
| +0.2% | +$1.43K | 0.02% | 396 |
|
|
2024
Q3 | $1.36M | Buy |
1,309
+60
| +5% | +$62.3K | 0.03% | 302 |
|
|
2024
Q2 | $1.31M | Buy |
1,249
+65
| +5% | +$68.3K | 0.03% | 275 |
|
|
2024
Q1 | $1.14M | Buy |
1,184
+1
| +0.1% | +$962 | 0.03% | 299 |
|
|
2023
Q4 | $1.04M | Buy |
1,183
+4
| +0.3% | +$3.51K | 0.03% | 286 |
|
|
2023
Q3 | $970K | Buy |
1,179
+8
| +0.7% | +$6.58K | 0.03% | 266 |
|
|
2023
Q2 | $841K | Sell |
1,171
-33
| -3% | -$23.7K | 0.03% | 297 |
|
|
2023
Q1 | $989K | Buy |
1,204
+36
| +3% | +$29.6K | 0.03% | 274 |
|
|
2022
Q4 | $843K | Buy |
+1,168
| New | +$843K | 0.03% | 290 |
|
|
2022
Q2 | $559K | Sell |
945
-3
| -0.3% | -$1.78K | 0.02% | 358 |
|
|
2022
Q1 | $662K | Buy |
948
+61
| +7% | +$42.6K | 0.02% | 303 |
|
|
2021
Q4 | $560K | Buy |
887
+475
| +115% | +$300K | 0.02% | 387 |
|
|
2021
Q3 | $231K | Sell |
412
-87
| -17% | -$48.8K | 0.01% | 358 |
|
|
2021
Q2 | $279K | Buy |
+499
| New | +$279K | 0.01% | 409 |
|
|
2021
Q1 | – | Sell |
-460
| Closed | -$222K | – | 455 |
|
|
2020
Q4 | $222K | Buy |
+460
| New | +$222K | 0.01% | 366 |
|
|
2020
Q3 | – | Sell |
-341
| Closed | -$213K | – | 325 |
|
|
2020
Q2 | $213K | Buy |
+341
| New | +$213K | 0.02% | 282 |
|
|
2015
Q4 | – | Sell |
-540
| Closed | -$251K | – | 215 |
|
|
2015
Q3 | $251K | Sell |
540
-5
| -0.9% | -$2.32K | 0.07% | 138 |
|
|
2015
Q2 | $278K | Buy |
+545
| New | +$278K | 0.07% | 132 |
|
|
2015
Q1 | – | Sell |
-545
| Closed | -$224K | – | 171 |
|
|
2014
Q4 | $224K | Buy |
+545
| New | +$224K | 0.06% | 152 |
|